title: [Prognosis value of the pp65 antigenemia and semi-quantitative PCR in the detection of the CMV reactivation in bone marrow grafted patients].
abstract: In this article a Cytomegalovirus (CMV) antigenemia and semiquantitative PCR retrospective evaluation of 26 bone marrow allo-grafted patients for different haematological disease is reported. Eighteen patients had a CMV reactivation despite a prophylactic treatment, seven of those patients had both positive antigenemia pp65 and positive semi-quantitative CMV PCR. During CMV reactivation, 3 patients developed a CMV disease despite a pre-emptive therapy. The follow up of the antigenemia was performed since D21 until D100 post transplantation, the antigenemia positivity occurred at D53 and was preceded about 7 days by CMV PCR positivity The CMV disease wasn't associated with a high viral load. All patients that had CMV reactivation had a positive CMV serology before the graft, whereas only 37.5% of the patients who did not reactivate had a positive CMV serology. Respectively half patients who reactivated and only 12.5% of those who didn't had a Graft versus host disease (GVHD), witch preceded the reactivation about 21 days in six of the formers. Clinical and biological signs presented by our patients in this cases report, seems to be associated more with the GVHD than with CMV reactivation.
authors.affiliation: Service des laboratoires du Centre national de greffe de moelle osseuse, Tunis, Tunisie. ksourih_2000@yahoo.fr
authors.forename: H
authors.initials: H
authors.lastname: Ksouri
authors.forename: A
authors.initials: A
authors.lastname: Lakhal
authors.forename: R
authors.initials: R
authors.lastname: Ben Amor
authors.forename: L
authors.initials: L
authors.lastname: Torjman
authors.forename: W
authors.initials: W
authors.lastname: Achour
authors.forename: T
authors.initials: T
authors.lastname: Ben Othmen
authors.forename: S
authors.initials: S
authors.lastname: Ladeb
authors.forename: A
authors.initials: A
authors.lastname: Abdelkefi
authors.forename: A
authors.initials: A
authors.lastname: Slim
authors.forename: A
authors.initials: A
authors.lastname: Abdeladhim
authors.forename: A
authors.initials: A
authors.lastname: Ben Hassen
mesh_terms: D000293:Adolescent; D000328:Adult; D000956:Antigens, Viral / Q000097:blood*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000097:blood* / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D010750:Phosphoproteins / Q000097:blood*; D016133:Polymerase Chain Reaction / Q000379:methods; D011379:Prognosis; D012189:Retrospective Studies; D014763:Viral Matrix Proteins / Q000097:blood*
chemical_list: D000956:Antigens, Viral; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa